GLOBAL DOUBLE STANDARDS
 |
James Joyner | Wednesday, July 30, 2003 |
Robert Kuttner thinks we’re being inconsistent by, on the one hand, exporting low skill jobs to India to take advantage of their lower labor costs but, on the other hand, refusing to import drugs from India produced in violation if US patent and drug approval laws. Well…..no.
It may well be worth reconsidering our drug approval process and the length of patent and copyright protections. But these are separate arguments. A US company can’t reverse engineer a patented product and sell it here, either. Nor can a US company sell drugs that aren’t FDA approved.
Related Stories:
- None Found
Recent Stories:
- Jesse Helms Dead at 86
- Happy 232nd Birthday, America
- Obama to ‘Refine’ Iraq Deadline, Keep it Exactly Same
- OTB Latenight - Leslie Feist
- Giving ‘Stimulus Package’ a Whole New Meaning
- U.S. Constitution: 4th Amendment
- Supreme Court Focus of 2008 Election
- Conservative Bloggers Silent On Torture?
- Is Your Washroom Breeding Bolsheviks?
- McCain Shakes Up Campaign Staff. Again.
Comments
Comments are Closed
